INKT - MiNK Therapeutics, Inc. Stock Price, Fair Value and News

$0.52+0.02 (+4.00%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

INKT Price Action

Last 7 days

-16.1%

Last 30 days

-25.7%

Last 90 days

-30.7%

Trailing 12 Months

-48.5%

INKT RSI Chart

INKT Valuation

Market Cap

20.6M

Price/Earnings (Trailing)

-1.49

Price/Free Cashflow

-1.89

INKT Price/Earnings (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

INKT Fundamentals

INKT Earnings

Earnings (TTM)

-13.8M

Earnings Growth (Yr)

64.69%

Earnings Growth (Qtr)

33.13%

INKT Profitability

Return on Equity

78.5%

Return on Assets

-186.86%

Free Cashflow Yield

-52.82%

INKT Investor Care

Shares Dilution (1Y)

14.57%

Diluted EPS (TTM)

-0.38

Revenue & Growth

About MiNK Therapeutics, Inc.

MiNK Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the discovery, development, and commercialization of allogeneic, off-the-shelf, invariant natural killer T (iNKT) cell therapies to treat cancer and other immune-mediated diseases. It's product candidate is AGENT-797, an off-the-shelf, allogeneic for iNKT cell therapy and treatment of various myeloma diseases and solid tumours, which is in Phase 1 clinical trials. The company was formerly known as AgenTus Therapeutics, Inc. MiNK Therapeutics, Inc. was incorporated in 2017 and is based in New York, New York.

CEO	Dr. Jennifer S. Buell Ph.D.
WEBSITE	https://minktherapeutics.com
SECTOR	Healthcare
INDUSTRY	Biotechnology
EMPLOYEES	37

MiNK Therapeutics, Inc. Frequently Asked Questions

What is the ticker symbol for MiNK Therapeutics, Inc.? What does INKT stand for in stocks?

INKT is the stock ticker symbol of MiNK Therapeutics, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MiNK Therapeutics, Inc. (INKT)?

As of Fri Dec 20 2024, market cap of MiNK Therapeutics, Inc. is 20.57 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INKT stock?

You can check INKT's fair value in chart for subscribers.

Is MiNK Therapeutics, Inc. a good stock to buy?

The fair value guage provides a quick view whether INKT is over valued or under valued. Whether MiNK Therapeutics, Inc. is cheap or expensive depends on the assumptions which impact MiNK Therapeutics, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INKT.